Better quality of life with regular check-ins for lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether having regular check-ins on your quality of life (like symptoms and daily well-being) can help you feel better during lung cancer treatment. It's for patients recently diagnosed with lung cancer who are getting care at select hospitals in Bavaria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must have a new lung cancer diagnosis confirmed by a biopsy (tissue sample) within the last 2 months
- Must be treated at one of six participating hospitals in Bavaria, Germany
- Must be able to fill out a quality-of-life questionnaire (with or without assistance)
- Must be 18 years or older and not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a web-based tool to track symptoms can help people with advanced lung cancer live longer and feel better. You would report symptoms regularly, and your care team would use that information to adjust your care.
This trial tests whether using a special lung ventilation scan can help doctors design radiation therapy that reduces side effects and improves quality of life for people with stage 3 non-small cell lung cancer.
This study helps doctors improve how they follow lung cancer treatment guidelines. If you join, your care and outcomes will be tracked to see if following guidelines leads to better results.
This study follows patients over time to see how anticancer treatments affect their quality of life. It's for adults who receive special cancer drugs and also get other support at the Rafael Institute.
This study asks people with neuroendocrine tumors to report how they’re doing, including quality of life and quality of care. Your answers can help doctors and hospitals understand what support works best.
This trial tests approved cancer drugs in people aged 70 and older with non-small-cell lung cancer who haven't had systemic treatment before. The goal is to see how well these drugs work in this older population.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.